Blood Screening Market Size Expected To Reach USD 4.86 Billion By 2027 Says Reports And Data

The global Blood Screening Market is forecast to reach USD 4.86 Billion by 2027, according to a new report by Reports and Data. The primary driving factors for the growth of the blood screening market is an increase in the prevalence of infectious diseases, rise in healthcare awareness, growth in the number of blood donations, and surge in NAT (nucleic acid amplification test).

North America accounted for the leading market share, owing to the increased prominence of blood tests, along with a large number of R&D activities taking place in the region. Presence of well-established and equipped health care organizations, government efforts in promoting the use of disposable blood bags, and constantly developing sterility aspects are some of the factors that would further fuel growth in the region.

The COVID-19 impact:

The market will witness a huge surge as biopharmaceutical innovators are in the front line for the human response to the global COVID-19 pandemic. A significant number of biotech firms are in the middle of the race to investigate the virus's genome and are preparing a viable vaccine. These companies are investigating the virus at an unprecedented rate, and considerable funds are being put into the research. The companies are in trial, and the public and private sectors are working continuously for the development of the vaccine. There is a huge demand for testing kits for the diagnosis of Sars-Cov-2, which will foster the demand for the market.

Key participants include:

Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Ortho-Clinical Diagnostics, Inc., Grifols, Siemens Healthcare GmbH, SOFINA S.A, and Thermo Fisher Scientific, Inc., among others.

Request sample copy of this report @ https://www.reportsanddata.com/sample-enquiry-form/3458

The COVID-19 impact:

The distribution of Covid-19's has influenced industrial activities worldwide. Over the weeks, the market has experienced a downturn that can continue in the coming months. The virus led to the implementation of lockdown, which disrupted the workings of the asset management program as the healthcare sector witnessed a collapse in several countries. They were loaded with patients infected by a coronavirus. Millions of people were infected, and thousands of them died, including the healthcare staff. Although the market suffered a major setback at the time, the industry is bouncing back as there is a greater need for better management and up-gradation of the medical sector.

Further key findings from the report suggest

The reagent and kits segment held a significant share owing to the accessibility of a wide range of reagents and the need for specific, reliable, and fast detection of blood screening. The growing demand for blood transfusion for the treatment of blood disorders contributed to the demand of the industry.

Nucleic acid testing (NAT) is a kind of molecular method deployed for in cases such as blood donations to screen the blood so as to decrease the danger of TTIs (transfusion-transmitted infections) in the individual receiving the blood. The main application of the nucleic acid test is associated with detecting viral RNAs and DNAs in a blood sample.

Hospitals held a larger market share due to the high number of cases recorded there. The segment is forecasted to grow with a CAGR of xx% during the forecast period…Continue

Order now@ https://www.reportsanddata.com/checkout-form/3458

For the purpose of this report, Reports and Data has segmented into the Global Blood Screening Market on the basis of material, application, and region:

Material Outlook (Revenue, USD Billion; 2017-2027)

Biologically Derived Materials
Synthetic Material
Others

Application Outlook (Revenue, USD Billion; 2017-2027)

Cancer
Urology
Neurology
Dental
Cell Banking & Cord blood
Gynecology
Integumentary/Skin
Spine, Musculoskeletal, & Orthopedics
Vascular & Cardiology

Regional Outlook (Revenue, USD Billion; 2017-2027)

North America
U.S
Canada
Europe
Germany
U.K
France
BENELUX
Rest of Europe
Asia Pacific
China
Japan
South Korea
Rest of APAC
MEA
Saudi Arabia
UAE
Rest of MEA
Latin America
Brazil
Rest of LATAM

Ask for discount@ https://www.reportsanddata.com/discount-enquiry-form/3458

Table of Contents:

Chapter 1. Market Synopsis

1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2019-2027

Chapter 3. Indicative Metrics

Chapter 4. Blood Screening Market Segmentation & Impact Analysis

4.1. Blood Screening Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market driver’s analysis

Continue…

Access Report Details @ https://www.reportsanddata.com/report-detail/blood-screening-market

Thank you for reading our report. If you have any request for customization, kindly connect with us and our team will assist you and ensure the report is tailored according to your needs.

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Our Innovative Blogs @ https://www.reportsanddata.com/blogs
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.